𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Aldose reductase is a potent regulator of TGF-β1 induced expression of fibronectin in human mesangial cells

✍ Scribed by Ping Huang; Yuejuan Zhang; Tao Jiang; Wenjiao Zeng; Nong Zhang

Publisher
Springer
Year
2009
Tongue
English
Weight
385 KB
Volume
37
Category
Article
ISSN
0301-4851

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulation of fibronectin and laminin re
Regulation of fibronectin and laminin receptor expression, fibronectin and laminin secretion in human colon cancer cells by transforming growth factor-β1
✍ Shuang Huang; Subhas Chakrabarty 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 638 KB

## Abstract Transforming growth factor (TGF)‐β~1~, modulates the expression of extracellular matrix (ECM) glycoproteins, fibronectin and laminin and the adhesion of Moser colon cancer cells to these glycoproteins. Since adhesion can be altered through expression of cell‐surface receptors, binding a

TGF-β-1 up-regulates cyclin D1 expressio
TGF-β-1 up-regulates cyclin D1 expression in colo-357 cells, whereas suppression of cyclin d1 levels is associated with down-regulation of the type I TGF-β receptor
✍ Marko Kornmann; Pam Tangvoranuntakul; Murray Korc 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 174 KB 👁 1 views

Transforming growth factor-␤1 (TGF-␤1) inhibits cell growth in susceptible cells by interacting with a family of protein kinases that control cell cycle progression. In the present study, we investigated the effects of TGF-␤1 on cyclin D1 expression and activity in COLO-357 human pancreatic cancer c

Transforming growth factor β1 (TGF-β1) i
Transforming growth factor β1 (TGF-β1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors
✍ S. Jozan; M. Guerrin; P. Mazars; M. Dutaur; B. Monsarrat; F. Cheutin; R. Bugat; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 957 KB

## Abstract The effects of EGF and TGF‐β1 on the proliferation of 2 ovarian carcinoma cell lines (IGROV1 and OVCCR1) were evaluated. The cell lines were adapted to grow in a restricted serum (0.5%) medium. EGF was required for proliferation of both ovarian cell lines. Low doses of TGF‐β1 inhibited